A clinical study that began in a research unit in Gqeberha (PE), Eastern Cape, has transformed global treatment of drug-resistant tuberculosis.

Tuberculosis is both curable and preventable, yet each year, it still kills more people than any other infectious disease. One reason is that current treatments hinge on rifampicin, an antibiotic that ...

SAN DIEGO (FOX 5/KUSI) — Anyone who attended St. Michael’s Catholic Church in the Paradise Hills area of San Diego from Sept. 22 to Dec. 1, 2024, is being warned they could have potentially been ...

Protocol can be used in children and pregnant women ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Tuberculosis (TB), one of the leading infectious disease killers ...

A new study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments. Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works ...

A clinical trial published in the New England Journal of Medicine showed that the oral antibiotic levofloxacin taken once-daily for six months substantially reduced the risk of developing ...

Only four out of 10 patients with extensively drug-resistant tuberculosis (TB) in Europe achieved successful treatment outcomes, a rate markedly lower than that for other forms of drug-resistant TB ...

An international research team headed by scientists at the University of British Columbia has demonstrated how a novel semi-synthetic compound derived from sanguinarine (SG), an alkaloid extracted ...

February 6, 2012 — Cases of multidrug-resistant tuberculosis (MDR-TB) hit an all-time high worldwide in 2009 and 2010, with 1 country reporting multidrug resistance in 65.1% of all previously treated ...

Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of the disease. Now, in a major step forward, an international clinical trial ...